It’s been a promising year for the domestic personalized nutrition/medicine market, with 23andMe launching an expanded direct-to-consumer genetic test after a two year battle with the Food and Drug Administration, Ancestry.com partnering with Quest Diagnostics to expand its DNA testing reach, and UBiome, Wellness FX, and Pathway Genomics all rolling out ambitious new products. Financial services firm UBS, which once doubted the category, is even saying it’s “increasingly opt
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.